Deal Library / Pharma BD Deal Intelligence

Pharma Deals of 2020

The Pharma Closeout tracks 230 deals, $188.5B in disclosed deal value, 32 with a post-close Outcome Score for the year 2020.

Median Critic Score: 80  ·  Median Outcome Score: 51

Best outcome: Pfizer Inc. / BioNTech SE (100)  ·  Weakest outcome: Gilead Sciences Inc. / Forty Seven Inc. (18)

All 230 deals

• Pfizer Inc. / BioNTech SE — 2020 · $748M · Worked — the deal delivered on its rationale.
• Servier / Agios Pharmaceuticals (oncology) — 2020 · $2.0B · Worked — the deal delivered on its rationale.
• Servier Pharmaceuticals LLC / Agios Pharmaceuticals Inc. — 2020 · $2.0B · Worked — the deal delivered on its rationale.
• Novo Nordisk A/S / Emisphere Technologies — 2020 · $1.4B · Worked — the deal delivered on its rationale.
• AstraZeneca PLC / Alexion Pharmaceuticals Inc. — 2020 · $39.0B · Worked — the deal delivered on its rationale.
• AstraZeneca PLC / Amgen Inc. — 2020 · $2.3B · Worked — the deal delivered on its rationale.
• AbbVie Inc. / Genmab A/S — 2020 · $3.9B · Worked — the deal delivered on its rationale.
• Bristol-Myers Squibb Company / MyoKardia Inc. — 2020 · $13.1B · Worked — the deal delivered on its rationale.
• Johnson & Johnson / Momenta Pharmaceuticals Inc. — 2020 · $6.5B · Largely worked — most objectives met.
• Amgen Inc. / BeiGene Ltd. — 2020 · $2.8B · Largely worked — most objectives met.
• Gilead Sciences Inc. / Immunomedics Inc. — 2020 · $21.0B · Largely worked — most objectives met.
• AstraZeneca PLC / Daiichi Sankyo Company, Limited — 2020 · $6.0B · Largely worked — most objectives met.
• Merck & Co. Inc. / VelosBio Inc. — 2020 · $2.8B · Largely worked — most objectives met.
• Illumina, Inc. / Amgen Inc. — 2020 · Mixed — partial payoff, real shortfalls.
• Bristol-Myers Squibb Company / Dragonfly Therapeutics Inc. — 2020 · $475M · Mixed — partial payoff, real shortfalls.
• Pfizer Inc. / CStone Pharmaceuticals — 2020 · $780M · Mixed — partial payoff, real shortfalls.
• GlaxoSmithKline plc / Vir Biotechnology Inc. — 2020 · $595M · Mixed — partial payoff, real shortfalls.
• Bayer AG / Asklepios BioPharmaceuticals — 2020 · $2.0B · Mixed — partial payoff, real shortfalls.
• Eli Lilly and Company / Prevail Therapeutics — 2020 · $1.0B · Mixed — partial payoff, real shortfalls.
• Bayer AG / Viralgen — 2020 · Mixed — partial payoff, real shortfalls.
• Novavax Inc. / Praha Vaccines — 2020 · $167M · Mixed — partial payoff, real shortfalls.
• Novartis AG / Molecular Partners AG — 2020 · $780M · Mixed — partial payoff, real shortfalls.
• Gilead Sciences Inc. / Arcus Biosciences, Inc. — 2020 · $5.0B · Mixed — partial payoff, real shortfalls.
• Sanofi SA / Kiadis Pharma NV — 2020 · $359M · Underwhelmed — fell short of the thesis.
• Sanofi SA / Principia Biopharma — 2020 · $3.7B · Underwhelmed — fell short of the thesis.
• Illumina, Inc. / GRAIL, Inc. — 2020 · $8.0B · Underwhelmed — fell short of the thesis.
• Metuchen Pharmaceuticals / Neurotrope Inc — 2020 · $20M · Underwhelmed — fell short of the thesis.
• Roche Holding AG / Blueprint Medicines Corporation — 2020 · $1.7B · Underwhelmed — fell short of the thesis.
• Merck & Co. Inc. / Seagen Inc. — 2020 · $4.2B · Did not work — the deal failed to deliver.
• Boehringer Ingelheim GmbH / NBE Therapeutics — 2020 · $1.5B · Did not work — the deal failed to deliver.
• AbbVie Inc. / I-Mab — 2020 · $2.9B · Did not work — the deal failed to deliver.
• Gilead Sciences Inc. / Forty Seven Inc. — 2020 · $4.9B · Did not work — the deal failed to deliver.
• NoveCite, Inc. / Novellus Therapeutics — 2020
• Janssen Biotech, Inc. / SpringWorks Therapeutics, Inc. — 2020
• Hypera S.A. / Takeda Pharmaceutical Company Ltd. — 2020 · $825M
• Takeda Pharmaceutical Company Limited / LogicBio Therapeutics Inc. — 2020
• Radius Health, Inc. / Guardant Health, Inc. — 2020
• AstraZeneca PLC / Allergan plc — 2020 · $250M
• Takeda Pharmaceutical Company Limited / Carmine Therapeutics — 2020
• Titan Pharmaceuticals, Inc. / JT Pharmaceuticals, Inc. — 2020
• Roche Holding AG / Atea Pharmaceuticals, Inc. — 2020 · $1.4B
• Eli Lilly and Company / Precision BioSciences, Inc. — 2020
• Vir Biotechnology / Harbour BioMed — 2020
• Sanofi SA / Kymera Therapeutics, Inc. — 2020 · $2.1B
• Pfizer Inc. / Vivet Therapeutics S.A.S. — 2020
• Janssen Biotech, Inc. / Guardant Health, Inc. — 2020
• Xediton Pharmaceuticals / Quantum Genomics — 2020 · $11M
• Sanofi / Alphamab Oncology — 2020
• ATAI Life Sciences AG / Neuronasal Inc. — 2020
• BioNTech / Neon Therapeutics, Inc. — 2020 · $67M
• Takeda Pharmaceutical Company Limited / Artisan Bio, Inc. — 2020
• SciClone Pharmaceuticals International Ltd. / EpicentRx, Inc. — 2020
• Processa Pharmaceuticals, Inc. / Aposense, LTD. — 2020
• Dynavax Technologies Corporation / Medigen Vaccine Biologics Corporation — 2020
• Editas Medicine, Inc. / Sandhill Therapeutics, Inc. — 2020
• Inceptua Group / Elevar Therapeutics, Inc. — 2020
• Biogen Inc. / Sage Therapeutics, Inc. — 2020
• Nascent Biotech, Inc / Manhattan BioSolutions, Inc. — 2020
• Norgine B.V. / AMAG Pharmaceuticals, Inc. — 2020
• Checkmate Pharmaceuticals, Inc. / Bristol Myers Squibb — 2020
• Oblique Therapeutics / Targovax ASA — 2020
• Forty Seven Inc. / Rocket Pharmaceuticals Inc. — 2020
• CSL Behring / uniQure N.V. — 2020
• Apollo Global Management, Inc. / Covis Pharma BV — 2020
• Rumpus Therapeutics / Denovo Biopharma LLC — 2020
• Bayer AG / Asklepios BioPharmaceutical, Inc. (AskBio) — 2020 · $4.0B
• Merck KGaA, Darmstadt, Germany / Artios Pharma Limited — 2020
• Ono Pharmaceutical / SK Biopharmaceuticals — 2020
• CStone Pharmaceuticals / LegoChem Biosciences, Inc. — 2020
• Intellia Therapeutics / Teneobio, Inc. — 2020
• Lyell Immunopharma / PACT Pharma — 2020
• Eli Lilly and Company / Dermira Inc. — 2020 · $1.1B
• Jazz Pharmaceuticals plc / SpringWorks Therapeutics, Inc. — 2020
• Horizon Therapeutics plc / Halozyme Therapeutics, Inc. — 2020
• Processa Pharmaceuticals, Inc. / Yuhan Corporation — 2020
• Nestle S.A. / Aimmune Therapeutics, Inc. — 2020 · $2.6B
• Allogene Therapeutics, Inc. / SpringWorks Therapeutics, Inc. — 2020
• Pfizer Inc. / SpringWorks Therapeutics, Inc. — 2020
• Processa Pharmaceuticals, Inc. / Elion Oncology, Inc. — 2020
• DongWha Pharm / Quantum Genomics — 2020 · $18M
• Swedish Orphan Biovitrum AB / Apellis Pharmaceuticals, Inc. — 2020 · $1.0B
• Orca Bio / Lyell Immunopharma — 2020
• Bristol-Myers Squibb Company / Repare Therapeutics Inc. — 2020 · $3.1B
• Servier / Symphogen A/S — 2020
• Genentech / Nimble Therapeutics, Inc. — 2020
• Hualan Genetic Engineering Co., Ltd / Harbour BioMed — 2020
• Johnson & Johnson / Fate Therapeutics, Inc. — 2020 · $3.1B
• Clover Biopharmaceuticals / Dynavax Technologies Corporation — 2020
• RedHill Biopharma Ltd. / AstraZeneca — 2020
• AbbVie / Frontier Medicines, Corp. — 2020
• Nuance Biotech Co. Ltd / Neumentum Inc. — 2020
• Zydus Cadila / XOMA Corporation — 2020
• UCB / Engage Therapeutics, Inc. — 2020
• CStone Pharmaceuticals / Burning Rock Biotech Limited — 2020
• Assembly Biosciences, Inc. / Arbutus Biopharma Corporation — 2020
• Merck & Co. Inc. / InxMed (Shanghai) Co., Ltd. — 2020
• Roivant Sciences / Affimed N.V. — 2020
• Eli Lilly and Company / Sermonix Pharmaceuticals Inc. — 2020
• Sumitomo Dainippon Pharma Co., Ltd. / Gain Therapeutics, Inc. — 2020
• Covis Group S.à r.l. / AMAG Pharmaceuticals, Inc. — 2020 · $498M
• Novo Nordisk / Fauna Bio — 2020
• GlaxoSmithKline plc / IDEAYA Biosciences, Inc. — 2020
• Santen Pharmaceutical Co., Ltd / RVL Pharmaceuticals, Inc. — 2020
• Zai Lab Limited / Cullinan Oncology — 2020
• Zai Lab / Turning Point Therapeutics Inc. — 2020
• BioMarin Pharmaceutical Inc. / DiNAQOR AG — 2020
• Pfizer Inc. / Valneva SE — 2020 · $308M
• Sarepta Therapeutics / Selecta Biosciences, Inc. — 2020
• Cutia Therapeutics (HK) Limited / Foamix Pharmaceuticals Ltd. — 2020
• Vifor Pharma / Cara Therapeutics — 2020
• Ultragenyx Pharmaceutical Inc. / Mereo BioPharma Group plc — 2020
• Aytu BioScience, Inc. / Neos Therapeutics, Inc. — 2020
• Alexion Pharmaceuticals Inc. / Portola Pharmaceuticals, Inc. — 2020 · $1.4B
• Anteris Bio / vTv Therapeutics LLC — 2020
• Merck & Co. Inc. / Highlight Therapeutics — 2020
• Unicycive Therapeutics, Inc. / Spectrum Pharmaceuticals — 2020
• AstraZeneca / Fusion Pharmaceuticals Inc. — 2020
• La Jolla Pharmaceutical Company / Tetraphase Pharmaceuticals, Inc. — 2020
• Takeda Pharmaceutical Company Limited / Evox Therapeutics Ltd — 2020 · $882M
• Bausch Health Companies Inc. / Allegro Ophthalmics, LLC — 2020
• Hikma Pharmaceuticals PLC / Glenmark Specialty S.A. — 2020
• Gilead Sciences, Inc. / Jounce Therapeutics Inc. — 2020
• Betta Pharmaceuticals / Agenus Inc. — 2020
• GSK / Surface Oncology — 2020
• Akers Biosciences, Inc. / Premas Biotech — 2020
• Beijing Shenogen Pharma Group / Alopexx Oncology, LLC — 2020
• Taysha Gene Therapies / Abeona Therapeutics Inc. — 2020
• Telix Pharmaceuticals Limited / TheraPharm GmbH — 2020
• Citrine Medicine / Bioprojet SCR — 2020
• GlaxoSmithKline plc / CureVac N.V. — 2020 · $960M
• Sosei Group Corporation / Captor Therapeutics S.A. — 2020
• AbbVie / Harbour BioMed — 2020
• Janssen Pharmaceuticals, Inc. / Exonate — 2020
• Almirall / Bioniz Therapeutics, Inc. — 2020
• Fosun Pharma / Raziel Therapeutics — 2020
• Merck & Co. Inc. / Taiho Pharmaceutical / Astex Pharmaceuticals — 2020 · $2.5B
• Takeda Pharmaceutical Company Limited / Novavax Inc. — 2020
• Ocumension Therapeutics / EyePoint Pharmaceuticals, Inc. — 2020
• Cerevel Therapeutics / ARYA Sciences Acquisition Corp II — 2020 · $445M
• Melinta Therapeutics, Inc. / Tetraphase Pharmaceuticals, Inc. — 2020
• Grifols / Alkahest, Inc. — 2020 · $146M
• PCI Biotech / DCprime — 2020
• Ritter Pharmaceuticals, Inc. / Qualigen, Inc. — 2020
• Shanghai Pharmaceuticals Holding Co., Ltd / ImmVira Group Company — 2020
• Sanofi SA / Translate Bio Inc. — 2020 · $2.3B
• Eli Lilly and Company / Seed Therapeutics — 2020
• Precision BioSciences, Inc. / SpringWorks Therapeutics, Inc. — 2020
• Orgenesis Inc. / Koligo Therapeutics, Inc. — 2020 · $15M
• Altavant Sciences / Onspira Therapeutics — 2020
• Kyorin Pharmaceutical Co., Ltd. / aTyr Pharma, Inc. — 2020
• Zogenix / Tevard Biosciences — 2020
• Kleo Pharmaceuticals, Inc. / Green Cross LabCell — 2020
• Tango Therapeutics / Medivir AB — 2020
• Roche / Vividion Therapeutics — 2020
• Bayer AG / Recursion Pharmaceuticals, Inc. — 2020 · $1.1B
• Eli Lilly and Company / Evox Therapeutics Ltd — 2020
• Boehringer Ingelheim / Mirati Therapeutics, Inc. — 2020
• Sanofi / Nurix Therapeutics Inc. — 2020
• Bavarian Nordic A/S / AdaptVac — 2020
• Antares Pharma, Inc. / Ferring Pharmaceuticals — 2020
• Pfizer Inc. / Myovant Sciences Ltd. — 2020 · $4.2B
• Rain Therapeutics Inc. / Daiichi Sankyo Company, Limited — 2020
• Simcere / Alphamab Oncology — 2020
• Biogen Inc. / Sangamo Therapeutics, Inc. — 2020 · $2.7B
• MSD / Ascentage Pharma — 2020
• Jeil Pharmaceutical Co., Ltd. / Rockwell Medical, Inc. — 2020
• Ultragenyx Pharmaceutical Inc. / Solid Biosciences Inc. — 2020
• Poseida Therapeutics Inc. / TScan Therapeutics, Inc. — 2020
• Sorrento Therapeutics Inc. / SmartPharm Therapeutics Inc. — 2020
• Blackstone Group Inc. / Alnylam Pharmaceuticals Inc. — 2020 · $2.0B
• China Grand Pharmaceutical and Healthcare Holdings Limited / Telix Pharmaceuticals Limited — 2020
• Beijing Advaccine Biotechnology Co. / Inovio Pharmaceuticals, Inc. — 2020
• Dynavax Technologies Corporation / Valneva SE — 2020
• ADVANZ PHARMA Corp. Limited / Correvio Pharma Corp. — 2020 · $76M
• Atreca, Inc. / Xencor, Inc. — 2020
• Shanghai Allist Pharmaceuticals Co., Ltd. / OCTIMET Oncology NV — 2020
• Vifor Pharma / Angion Biomedica Corp. — 2020
• Myokardia / Fulcrum Therapeutics — 2020
• PTC Therapeutics Inc. / Censa Pharmaceuticals — 2020 · $268M
• Arctic Vision / Clearside Biomedical, Inc. — 2020
• AnHeart Therapeutics Co., Ltd. / Daiichi Sankyo Company, Limited — 2020
• BeiGene Ltd. / Hutchison China MediTech Limited — 2020
• Roche / UCB — 2020 · $2.0B
• Brickell Biotech, Inc. / AnGes, Inc. — 2020
• Teijin Pharma Limited / TransThera Biosciences Co. Ltd. — 2020
• Faran / Quantum Genomics — 2020 · $12M
• Genentech / Relay Therapeutics, Inc. — 2020
• Takeda Pharmaceutical Company Limited / Codexis, Inc. — 2020
• JW Therapeutics / Acepodia — 2020
• Recordati / ARS Pharmaceuticals — 2020
• Endo International plc / BioSpecifics Technologies Corp. — 2020 · $658M
• Oncologie, Inc. / Mereo BioPharma Group plc — 2020
• Boehringer Ingelheim GmbH / NBE-Therapeutics AG — 2020 · $1.4B
• EverInsight Therapeutics Inc. / VistaGen Therapeutics — 2020
• CSL Behring / Vitaeris Inc. — 2020
• ONK Therapeutics Ltd. / Glycotope GmbH — 2020
• Shanghai Haini Pharmaceutical Co., Ltd. / Allecra Therapeutics — 2020 · $78M
• Sirnaomics Inc. / Innovent Biologics, Inc. — 2020
• MSD / NETRIS Pharma SAS — 2020
• Junshi Biosciences / Wigen Biomedicine — 2020
• Menarini Group / Radius Health, Inc. — 2020
• Artiva Biotherapeutics, Inc. / Affimed N.V. — 2020
• Sarepta Therapeutics Inc. / Codiak BioSciences, Inc. — 2020
• ASKA Pharmaceutical Co., Ltd. / KinoPharma, Inc. — 2020
• EyePoint Pharmaceuticals, Inc. / Equinox Science, LLC — 2020
• Eli Lilly and Company / Shanghai Junshi Biosciences Co., Ltd. — 2020 · $255M
• Consilient Health, Ltd. / Aeterna Zentaris Inc. — 2020
• Dynavax Technologies Corporation / Sinovac Biotech Ltd. — 2020
• Eli Lilly and Company / Disarm Therapeutics — 2020
• Roche Holding AG / Regeneron Pharmaceuticals, Inc. — 2020
• Citius Pharmaceuticals, Inc. / Novellus, Inc. — 2020
• Innovent Biologics / Alector, Inc. — 2020
• CASI Pharmaceuticals, Inc. / BioInvent International AB — 2020
• Sperogenix Therapeutics / Minoryx Therapeutics — 2020
• AcelRx Pharmaceuticals, Inc. / Tetraphase Pharmaceuticals, Inc. — 2020 · $14M
• Moderna, Inc. / Lonza Group AG — 2020
• Roche Holding AG / Bicycle Therapeutics plc — 2020 · $1.7B
• Nestle S.A. / Allergan plc — 2020
• Assembly Biosciences, Inc. / Door Pharmaceuticals, LLC — 2020
• BeiGene / Assembly Biosciences — 2020
• Merck & Co. Inc. / Celyad Oncology SA — 2020
• Qilu Pharmaceutical / Quantum Genomics — 2020 · $50M
• Iovance Biotherapeutics, Inc. / Cellectis — 2020
• iBio, Inc. / Planet Biotechnology Inc. — 2020
• Genor Biopharma Co. Inc. / G1 Therapeutics, Inc. — 2020
• Menarini Group / Stemline Therapeutics Inc. — 2020 · $677M
• Kleo Pharmaceuticals, Inc. / Celularity Inc — 2020
• Ionis Pharmaceuticals, Inc. / Akcea Therapeutics, Inc. — 2020 · $500M
• Axsome Therapeutics, Inc. / Pfizer Inc. — 2020
• PharmaEssentia Corporation / Axis Therapeutics Limited — 2020

← Deal Library  ·  Interactive search  ·  How we score deals